NYSE:HQL

Tekla Life Sciences Investors (HQL) Stock Forecast, Price & News

$13.80

-0.03 (-0.22%)

(As of 05/19/2023 08:48 PM ET)

Compare

Today's Range: $13.76
▼
$13.99
50-Day Range: $13.37
▼
$14.17
52-Week Range: $13.03
▼
$16.33

Volume: 229,500 shs
Average Volume: 51,445 shs
Market Capitalization: $346.93 million

P/E Ratio: N/A
Dividend Yield: 9.42%
Price Target: N/A

About Tekla Life Sciences Investors (NYSE:HQL) Stock

Tekla Life Sciences Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Stock News Headlines

May 18, 2023 | americanbankingnews.com

Tekla Life Sciences Investors (HQL) To Go Ex-Dividend on May 24th

May 17, 2023 | msn.com

Tekla Life Sciences Investors (HQL) Declares $0.32 Dividend

May 22, 2023 | Legacy Research (Affiliate) (Ad)

The One Ticker Retirement Plan Over the Shoulder Demo Now Available

Market Wizard Larry Benedict crushed the market in 2022. But he hasn’t done it with a “traditional” method… For a limited time, he’s sharing a free over-the-shoulder “demo” of his strategy in action.

May 15, 2023 | msn.com

Tekla Life Sciences dividend declines by 3% to $0.32

March 21, 2023 | seekingalpha.com

HQL Tekla Life Sciences Investors

November 18, 2022 | msn.com

Tekla Life Sciences: Dividend Insights

November 2, 2022 | fool.com

Tekla Life Sciences Investors (NYSE: HQL)

July 14, 2022 | seekingalpha.com

HQL: A Biotechnology Equity CEF With No Leverage

May 22, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

June 8, 2022 | news.yahoo.com

Tekla Looks to Hazy Summer Days for New 'High Summer' Sleepwear Capsule

May 17, 2022 | seekingalpha.com

Tekla Life Sciences cuts dividend by 10% to $0.35

April 27, 2022 | seekingalpha.com

HQL: Buy For The Yield, If You Can Stomach The Depreciation

February 11, 2022 | seekingalpha.com

Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend

January 18, 2022 | nasdaq.com

Tekla Life Sciences Investors Shares Approach 52-Week Low - Market Mover

August 15, 2021 | forbes.com

5 Dividend Funds Yielding Up To 27.2%

August 13, 2021 | nasdaq.com

Tekla Life Sciences Investors Shares Close in on 52-Week High - Market Mover

February 17, 2021 | benzinga.com

Tekla Life Sciences Increases Dividend From $0.40 To $0.43

January 9, 2021 | seekingalpha.com

Tekla Life Sciences Investors: 8% Yield, 7% Discount

December 21, 2020 | finance.yahoo.com

Tekla Life Sciences Investors Declares Cash Distribution

November 24, 2020 | benzinga.com

Understanding Tekla Life Sciences's Ex-Dividend Date

November 16, 2020 | finance.yahoo.com

Tekla Life Sciences Investors Declares Distribution

November 9, 2020 | seekingalpha.com

HQH: Deep Discount Leads To High Yield

May 15, 2020 | www.nasdaq.com

HQL TeklaLife Sciences Investors Common Stock

March 19, 2020 | finance.yahoo.com

Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program

February 18, 2020 | seekingalpha.com

Tekla Life Sciences declares $0.39 dividend

February 18, 2020 | finance.yahoo.com

Tekla Life Sciences Investors Declares Stock Distribution

January 24, 2020 | finance.yahoo.com

Top Picks 2020- Tekla Life Sciences Fund HQL

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Company Calendar

Ex-Dividend for 3/31 Dividend: 2/24/2023
Dividend Payable: 3/31/2023
Today: 5/22/2023
Ex-Dividend for 6/30 Dividend: 5/24/2023
Dividend Payable: 6/30/2023
Fiscal Year End: 9/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Investment offices, not elsewhere classified
Sub-Industry: N/A
Sector: Finance
Current Symbol: NYSE:HQL
CUSIP: N/A
CIK: 884121
Web: www.teklacap.com
Phone: (617) 772-8500
Fax: 617-772-8577
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 25,140,000
Free Float: 22,615,000
Market Cap: $346.93 million
Optionable: Not Optionable
Beta: 0.83

Key Executives

Dan Omstead
President & Trustee

Jason C. Akus
Senior Vice President-Research

Laura F. Woodward
Secretary, Treasurer & Chief Compliance Officer

Timothy L. Gasperoni
Senior Vice President-Research

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

HQL Stock - Frequently Asked Questions

How have HQL shares performed in 2023?: Tekla Life Sciences Investors' stock was trading at $14.21 at the beginning of 2023. Since then, HQL shares have decreased by 2.9% and is now trading at $13.80.
View the best growth stocks for 2023 here.
How often does Tekla Life Sciences Investors pay dividends? What is the dividend yield for Tekla Life Sciences Investors?: Tekla Life Sciences Investors announced a quarterly dividend on Tuesday, May 16th. Stockholders of record on Thursday, May 25th will be given a dividend of $0.32 per share on Friday, June 30th. This represents a $1.28 annualized dividend and a dividend yield of 9.28%. The ex-dividend date is Wednesday, May 24th.
Read our dividend analysis for HQL.
What ETFs hold Tekla Life Sciences Investors' stock?: ETFs with the largest weight of Tekla Life Sciences Investors (NYSE:HQL) stock in their portfolio include First Trust Income Opportunity ETF (FCEF),
Is Tekla Life Sciences Investors a good dividend stock?: Tekla Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.30 per share and currently has a dividend yield of 9.40%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for HQL.
What other stocks do shareholders of Tekla Life Sciences Investors own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY).

What is Tekla Life Sciences Investors' stock symbol?: Tekla Life Sciences Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQL."
Who are Tekla Life Sciences Investors' major shareholders?: Tekla Life Sciences Investors' stock is owned by many different retail and institutional investors. Top institutional shareholders include Raymond James & Associates (1.23%), Wolverine Asset Management LLC (1.22%), Allspring Global Investments Holdings LLC (0.87%), LPL Financial LLC (0.67%), 180 Wealth Advisors LLC (0.44%) and Advisors Asset Management Inc. (0.43%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead and Kathleen Goetz.
View institutional ownership trends.
How do I buy shares of Tekla Life Sciences Investors?: Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Tekla Life Sciences Investors' stock price today?: One share of HQL stock can currently be purchased for approximately $13.80.
How much money does Tekla Life Sciences Investors make?: Tekla Life Sciences Investors (NYSE:HQL) has a market capitalization of $346.93 million.
How can I contact Tekla Life Sciences Investors?: Tekla Life Sciences Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The official website for the company is www.teklacap.com. The company can be reached via phone at (617) 772-8500, via email at info@teklacap.com, or via fax at 617-772-8577.

This page (NYSE:HQL) was last updated on 5/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial